These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27102151)

  • 1. Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014).
    Pan B; Yao R; Shi J; Xu QQ; Zhou YD; Mao F; Lin Y; Guan JH; Wang XJ; Zhang YN; Zhang XH; Shen SJ; Zhong Y; Xu YL; Zhu QL; Liang ZY; Sun Q
    Oncotarget; 2016 Jun; 7(25):38864-38875. PubMed ID: 27102151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and prognosis of mucinous breast carcinoma.
    Zhang M; Teng XD; Guo XX; Zhao JS; Li ZG
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):265-9. PubMed ID: 24305754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure and Mixed Mucinous Carcinoma of the Breast: A Comparison of Clinical Outcomes and Treatment Results.
    Skotnicki P; Sas-Korczynska B; Strzepek L; Jakubowicz J; Blecharz P; Reinfuss M; Walasek T
    Breast J; 2016 Sep; 22(5):529-34. PubMed ID: 27261206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-lesion histogram analysis of the apparent diffusion coefficient: Evaluation of the correlation with subtypes of mucinous breast carcinoma.
    Guo Y; Kong QC; Zhu YQ; Liu ZZ; Peng LR; Tang WJ; Yang RM; Xie JJ; Liu CL
    J Magn Reson Imaging; 2018 Feb; 47(2):391-400. PubMed ID: 28640538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma.
    Kashiwagi S; Onoda N; Asano Y; Noda S; Kawajiri H; Takashima T; Ohsawa M; Kitagawa S; Hirakawa K
    Springerplus; 2013; 2():481. PubMed ID: 24156087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of imaging and pathology features of mucinous carcinoma of the breast.
    Zhang L; Jia N; Han L; Yang L; Xu W; Chen W
    Clin Breast Cancer; 2015 Apr; 15(2):e147-54. PubMed ID: 25523373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncotype DX 21-gene test has a low recurrence score in both pure and mixed mucinous breast carcinoma.
    Chen R; Wang Y; Li T; Lv J; Feng G; Tan N; Wang J; Cheng X
    Oncol Lett; 2021 Nov; 22(5):771. PubMed ID: 34589150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L
    Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological evaluation of 100 cases of mucinous carcinoma of breast with emphasis on axillary staging and special reference to a micropapillary pattern.
    Ranade A; Batra R; Sandhu G; Chitale RA; Balderacchi J
    J Clin Pathol; 2010 Dec; 63(12):1043-7. PubMed ID: 20962055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Ultrasound-Based Multilayer Perceptron to Differentiate Early Breast Mucinous Cancer and its Subtypes From Fibroadenoma.
    Liang T; Shen J; Zhang S; Cong S; Liu J; Pei S; Shang S; Huang C
    Front Oncol; 2021; 11():724656. PubMed ID: 34926246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.
    Gwark SC; Lee HS; Lee Y; Lee SB; Sohn G; Kim J; Chung IY; Ko BS; Kim HJ; Son BH; Ahn JH; Jung KH; Kim SB; Lee HJ; Gong GY; Ahn SH; Lee JW
    Ann Surg Oncol; 2019 Jul; 26(7):2166-2174. PubMed ID: 30977015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
    Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
    Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
    Fujimoto Y; Watanabe T; Hida AI; Higuchi T; Miyagawa Y; Ozawa H; Bun A; Fukui R; Sata A; Imamura M; Hirota S; Miyoshi Y
    Breast Cancer; 2019 Nov; 26(6):738-747. PubMed ID: 31098866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology.
    Uyeturk U; Oksuzoglu B; Akman T; Turker I; Sener N; Tastekin D; Bal O; Berk V; Arslan UY; Urakci Z; Bilir C; Yilmaz U; Yazilitas D; Ulas A; Sonmez OU; Budakoglu B; Cihan S; Uysal M
    Med Oncol; 2014 Apr; 31(4):929. PubMed ID: 24659267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study.
    Wu J; Ding S; Lin L; Fei X; Lin C; Andriani L; Goh C; Huang J; Hong J; Gao W; Zhu S; Wang H; Huang O; Chen X; He J; Li Y; Shen K; Chen W; Zhu L
    Cancer Res Treat; 2020 Jul; 52(3):671-679. PubMed ID: 32019280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer.
    Fushimi A; Yoshida A; Yagata H; Takahashi O; Hayashi N; Suzuki K; Tsunoda H; Nakamura S; Yamauchi H
    Surg Today; 2019 Mar; 49(3):224-230. PubMed ID: 30317491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Ono M; Tsuda H; Yoshida M; Shimizu C; Kinoshita T; Tamura K
    Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.